These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 17594758)

  • 21. Open-label, long-term safety study of zonisamide administered to children and adolescents with epilepsy.
    Shinnar S; Pellock JM; Conry JA
    Eur J Paediatr Neurol; 2009 Jan; 13(1):3-9. PubMed ID: 18343174
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of zonisamide: results of a multicenter study.
    Leppik IE; Willmore LJ; Homan RW; Fromm G; Oommen KJ; Penry JK; Sackellares JC; Smith DB; Lesser RP; Wallace JD
    Epilepsy Res; 1993 Feb; 14(2):165-73. PubMed ID: 8453952
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Practical prescribing and long-term efficacy and safety of zonisamide.
    Leppik IE
    Epilepsy Res; 2006 Feb; 68 Suppl 2():S17-24. PubMed ID: 16406743
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Zonisamide: its pharmacology, efficacy and safety in clinical trials.
    Brodie MJ; Ben-Menachem E; Chouette I; Giorgi L
    Acta Neurol Scand Suppl; 2012; (194):19-28. PubMed ID: 23106522
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Zonisamide in pediatric epilepsy: review of the Japanese experience.
    Glauser TA; Pellock JM
    J Child Neurol; 2002 Feb; 17(2):87-96. PubMed ID: 11952083
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and effectiveness of topiramate for the management of painful diabetic peripheral neuropathy in an open-label extension study.
    Donofrio PD; Raskin P; Rosenthal NR; Hewitt DJ; Jordan DM; Xiang J; Vinik AI;
    Clin Ther; 2005 Sep; 27(9):1420-31. PubMed ID: 16291415
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized phase III trial of adjunctive zonisamide in pediatric patients with partial epilepsy.
    Guerrini R; Rosati A; Segieth J; Pellacani S; Bradshaw K; Giorgi L
    Epilepsia; 2013 Aug; 54(8):1473-80. PubMed ID: 23837461
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Review of zonisamide development in Japan.
    Seino M
    Seizure; 2004 Dec; 13 Suppl 1():S2-4. PubMed ID: 15511683
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term efficacy and safety of monotherapy and adjunctive therapy with zonisamide.
    Tosches WA; Tisdell J
    Epilepsy Behav; 2006 May; 8(3):522-6. PubMed ID: 16542880
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk factors for hyperammonemia in pediatric patients with epilepsy.
    Yamamoto Y; Takahashi Y; Imai K; Mishima N; Yazawa R; Inoue K; Itoh K; Kagawa Y; Inoue Y
    Epilepsia; 2013 Jun; 54(6):983-9. PubMed ID: 23409971
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence of kidney stones with topiramate treatment in pediatric patients.
    Mahmoud AA; Rizk T; El-Bakri NK; Riaz M; Dannawi S; Al Tannir M
    Epilepsia; 2011 Oct; 52(10):1890-3. PubMed ID: 21883178
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical efficacy of zonisamide in childhood epilepsy after long-term treatment: a postmarketing, multi-institutional survey.
    Iinuma K; Haginoya K
    Seizure; 2004 Dec; 13 Suppl 1():S34-9; discussion S40. PubMed ID: 15511687
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Urolithiasis on the ketogenic diet with concurrent topiramate or zonisamide therapy.
    Paul E; Conant KD; Dunne IE; Pfeifer HH; Lyczkowski DA; Linshaw MA; Thiele EA
    Epilepsy Res; 2010 Jun; 90(1-2):151-6. PubMed ID: 20466520
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of zonisamide: our experience.
    Yamauchi T; Aikawa H
    Seizure; 2004 Dec; 13 Suppl 1():S41-8; discussion S49. PubMed ID: 15511689
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Randomized, controlled clinical trial of zonisamide as adjunctive treatment for refractory partial seizures.
    Sackellares JC; Ramsay RE; Wilder BJ; Browne TR; Shellenberger MK
    Epilepsia; 2004 Jun; 45(6):610-7. PubMed ID: 15144425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Zonisamide for weight loss in obese adults: a randomized controlled trial.
    Gadde KM; Franciscy DM; Wagner HR; Krishnan KR
    JAMA; 2003 Apr; 289(14):1820-5. PubMed ID: 12684361
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Zonisamide - induced urinary lithiasis in patients with intractable epilepsy.
    Kubota M; Nishi-Nagase M; Sakakihara Y; Noma S; Nakamoto M; Kawaguchi H; Yanagisawa M
    Brain Dev; 2000 Jun; 22(4):230-3. PubMed ID: 10838109
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and tolerability of zonisamide versus controlled-release carbamazepine for newly diagnosed partial epilepsy: a phase 3, randomised, double-blind, non-inferiority trial.
    Baulac M; Brodie MJ; Patten A; Segieth J; Giorgi L
    Lancet Neurol; 2012 Jul; 11(7):579-88. PubMed ID: 22683226
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Zonisamide: pharmacokinetics, efficacy, and adverse events in children with epilepsy.
    Wallander KM; Ohman I; Dahlin M
    Neuropediatrics; 2014 Dec; 45(6):362-70. PubMed ID: 25133701
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Zonisamide for migraine prophylaxis in topiramate-intolerant patients: an observational study.
    Villani V; Ciuffoli A; Prosperini L; Sette G
    Headache; 2011 Feb; 51(2):287-91. PubMed ID: 21284610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.